Editorial Board
Zhi-Ling YU
Associate Director, Technology Development Division, School of Chinese Medicine, Hong Kong Baptist University · China
Editorial leadership for International Journal of Nutrition ISSN 2379-7835
Research interests
- Pharmacology Of Chinese Medicines Exhibiting Anticancer
- Anti-Inflammation
- Anti-Fatty Liver Properties
- Improving Learning
- Memory
- And Affecting Melanogenesis. Pathophysiology Of Cancer
- Nonalcoholic Fatty Liver Disease
Biography
- Zhi-Ling Yu obtained a Bachelor degree of Pharmacy in Chinese Medicine from Henan College of Chinese Medicine, Zhengzhou, China and a PhD degree in Biochemistry from Hong University of Science and Technology, Hong Kong.
- Currently He is studying anticancer, antiinflammation and antifatty liver Chinese herbs using molecular biology approaches in Hong Kong Baptist University as an associate professor.
- Dr. Zhi-Ling YU is presently working as a Professor in the school of Chinese medicine, at Hong Kong Baptist University, China.
- Until 2014 he worked as a CEO at Institute for the Advancement of Chinese Medicine (IACM) Ltd, in the Hong Kong Baptist University, China.
- He received his Ph.D. in Biochemistry, Hong Kong University of Science and Technology, china.
- He had number of research outputs in the field of Nanoscience.
- And he is also a responsible member in professional societies and Organizing Committees.
- Pharmacology of Chinese medicines exhibiting anticancer, anti-inflammation and anti-fatty liver properties, improving learning and memory, and affecting melanogenesis.
- Pathophysiology of cancer and nonalcoholic fatty liver disease.
Considering IJN for your work?
This journal is guided by Zhi-Ling YU (Associate Director, Technology Development Division, School of Chinese Medicine, Hong Kong Baptist University) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.